MIAMI, FL, May 14, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality ...
Need a quote from a Motley Fool analyst? With me on this morning's call are Dr. Gary Barnette, the Chief Scientific Officer; Michelle Greco, the Chief Financial Officer and Chief Administrative ...
Good morning, ladies and gentlemen, and welcome to Veru Inc. Investors Conference Call. [Operator Instructions] Please note that this event is being recorded. I would now like to turn the conference ...
Veru Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to the Veru Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results